Cell Mol Immunol (2019) 16(10):7919
This product is for laboratory research use only (RUO) not for human or veterinary use
Side effects might include stomach upset, drowsiness, loss or gain of appetite, or irritation of the injection site
After reconstitution (with sterile water): Use immediately and discard any remaining solution
Factors such as cost savings, convenience, absorption issues, potential digestion, and comfort with self-administering injections can affect patients preferences
The practical result, in our clinical experience, is that patients with a subacute tendinopathy that has stalled at 6 to 12 weeks of physical therapy tend to notice a meaningful change in pain level and range of motion within 3 to 4 weeks of starting a BPC-157 protocol